Display options
Cite
Togashi K, Fujita T, Utano K, et al. Gastrografin as an alternative booster to sodium phosphate in colon capsule endoscopy: safety and efficacy pilot study. Endosc Int Open. 2015;3(6):E659-61doi: 10.1055/s-0034-1393075.
Togashi, K., Fujita, T., Utano, K., Waga, E., Katsuki, S., Isohata, N., Endo, S., & Lefor, A. K. (2015). Gastrografin as an alternative booster to sodium phosphate in colon capsule endoscopy: safety and efficacy pilot study. Endoscopy international open, 3(6), E659-61. https://doi.org/10.1055/s-0034-1393075
Togashi, Kazutomo, et al. "Gastrografin as an alternative booster to sodium phosphate in colon capsule endoscopy: safety and efficacy pilot study." Endoscopy international open vol. 3,6 (2015): E659-61. doi: https://doi.org/10.1055/s-0034-1393075
Togashi K, Fujita T, Utano K, Waga E, Katsuki S, Isohata N, Endo S, Lefor AK. Gastrografin as an alternative booster to sodium phosphate in colon capsule endoscopy: safety and efficacy pilot study. Endosc Int Open. 2015 Dec;3(6):E659-61. doi: 10.1055/s-0034-1393075. Epub 2015 Sep 23. PMID: 26716132; PMCID: PMC4683135.
Copy Download .nbib Format: NLM
Share it on

Endosc Int Open. 2015 Dec;3(6):E659-61. doi: 10.1055/s-0034-1393075. Epub 2015 Sep 23.

Gastrografin as an alternative booster to sodium phosphate in colon capsule endoscopy: safety and efficacy pilot study.

Endoscopy international open

Kazutomo Togashi, Tomoki Fujita, Kenichi Utano, Eriko Waga, Shinichi Katsuki, Noriyuki Isohata, Shungo Endo, Alan K Lefor

Affiliations

  1. Department of Coloproctology, Aizu Medical Center, Fukushima Medical University, Aizuwakamatsu-city, Japan.
  2. Department of Gastroenterology, Otaru Ekiseikai General Hospital, Otaru, Japan.
  3. Department of Surgery, Jichi Medical University, Shimotsuke, Japan.

PMID: 26716132 PMCID: PMC4683135 DOI: 10.1055/s-0034-1393075

Abstract

BACKGROUND AND STUDY AIMS: Sodium phosphate is a key component of bowel preparation regimen for colon capsule endoscopy (CCE), but may cause serious complications. The aim of this study is to evaluate the use of Gastrografin, substituted for sodium phosphate, in CCE bowel preparation.

PATIENTS AND METHODS: In total, 29 patients (median age 64 years; 23 females) underwent CCE, covered by the national health insurance system of Japan. All had a history of laparotomy and/or previously incomplete colonoscopy. On the day before examination, patients ingested 1 L of polyethylene glycol + ascorbic acid with 0.5 L of water in the evening, and again the same laxative on the morning of examination. After capsule ingestion, 50 mL of Gastrografin diluted with 0.9 L of magnesium citrate was administered, and then repeated after 1 hour.

RESULTS: The capsule excretion rate was 97 % (28/29). The median colon transit time was 2 hours 45 minutes and rapid transit (< 40 minutes) through the colon occurred in one patient (3.4 %). Bowel cleansing level was adequate in 90 % of patients. The polyp (≥ 6 mm) detection rate was 52 %. Diluted Gastrografin was well tolerated by patients. No adverse events occurred.

CONCLUSION: Gastrografin can be an alternative to sodium phosphate in CCE bowel preparation regimen.

References

  1. Am J Gastroenterol. 2009 Apr;104(4):848-54 - PubMed
  2. N Engl J Med. 2008 Sep 18;359(12 ):1207-17 - PubMed
  3. Hum Pathol. 2004 Jun;35(6):675-84 - PubMed
  4. Gut. 2015 Feb;64(2):272-81 - PubMed
  5. Therap Adv Gastroenterol. 2014 May;7(3):115-22 - PubMed
  6. Endoscopy. 2006 Oct;38(10):963-70 - PubMed
  7. Clin Gastroenterol Hepatol. 2014 Aug;12(8):1303-10 - PubMed
  8. J Clin Gastroenterol. 2011 Feb;45(2):119-24 - PubMed
  9. Gastroenterology. 2015 May;148(5):948-957.e2 - PubMed
  10. Endoscopy. 2006 Oct;38(10):971-7 - PubMed
  11. N Engl J Med. 2009 Jul 16;361(3):264-70 - PubMed
  12. Colorectal Dis. 2011 Sep;13(9):e270-5 - PubMed

Publication Types